NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT00085449 2019-11-27Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerAlliance for Clinical Trials in OncologyPhase 1/2 Withdrawn
NCT00579111 2016-05-04Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)Baylor College of MedicinePhase 1/2 Terminated4 enrolled 8 charts
NCT00056966 2012-06-29Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesBaylor College of MedicinePhase 1/2 Completed24 enrolled